New Zealand markets open in 9 hours 7 minutes

Bio-Rad Laboratories, Inc. (BIO)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
421.93+3.38 (+0.81%)
At close: 04:05PM EDT
421.93 +0.06 (+0.01%)
After hours: 04:05PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
2,870,979
2,922,545
2,545,626
2,311,659
2,289,415
Cost of revenue
1,233,002
1,281,884
1,107,804
1,054,663
1,066,264
Gross profit
1,637,977
1,640,661
1,437,822
1,256,996
1,223,151
Operating expenses
Research development
263,931
271,657
226,598
202,710
199,196
Selling general and administrative
846,620
879,574
800,267
824,625
834,783
Total operating expenses
1,110,551
1,151,231
1,026,865
1,027,335
1,033,979
Operating income or loss
527,426
489,430
410,957
229,661
189,172
Interest expense
15,558
1,551
21,861
23,416
23,962
Total other income/expenses net
-3,159,165
4,931,395
4,500,354
2,024,342
320,856
Income before tax
-2,609,726
5,438,149
4,907,638
2,261,081
512,659
Income tax expense
-667,303
1,192,247
1,101,371
502,406
147,045
Income from continuing operations
-1,942,423
4,245,902
3,806,267
1,758,675
365,614
Net income
-1,942,423
4,245,902
3,806,267
1,758,675
365,614
Net income available to common shareholders
-1,942,423
4,245,902
3,806,267
1,758,675
365,614
Basic EPS
-
142.33
127.86
58.93
12.10
Diluted EPS
-
140.56
126.20
58.27
11.94
Basic average shares
-
29,831
29,768
29,843
29,836
Diluted average shares
-
30,208
30,160
30,184
30,228
EBITDA
-
5,573,500
5,067,599
2,418,697
674,721